DOI:
10.1055/s-00050348
Indian Journal of Medical and Paediatric Oncology
LinksSchließen
Referenz
Sandler HM, Hu C, Rosenthal SA, Sartor O, Gomell LG. et al.
A phase III protocol of androgen suppression (AS) and 3DCRT/IMRT versus AS and 3DCRT/IMRT followed by chemotherapy (CT) with docetaxel and prednisone for localized, high-risk prostate cancer (RTOG 0521).
J Clin Oncol 2015;
18 Suppl 33: LBA5002
Für die Inhalte der Internetseiten anderer Anbieter übernehmen wir keine Verantwortung.